What is ProMIS Neurosciences Inc. (PMN) stock price today?

ProMIS Neurosciences Inc. (PMN) currently trades at $11.15 per share. The stock has a market capitalization of $99.99M and a P/E ratio of —x.

Is PMN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, ProMIS Neurosciences Inc. has a Smart Value Score of 19/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is ProMIS Neurosciences Inc.'s revenue and earnings?

ProMIS Neurosciences Inc. has trailing twelve-month (TTM) revenue of $7560.00 with profit margins of 0.00%. Earnings per share (EPS) is $-22.61.

PMN

ProMIS Neurosciences Inc.

NASDAQ: PMN · HEALTHCARE · BIOTECHNOLOGY

$11.15

+2.76% today

Updated 2026-04-29

Market cap

$99.99M

P/E ratio

—

P/S ratio

4,016.22x

EPS (TTM)

$-22.61

Dividend yield

—

52W range

$6 – $40

Volume

0.0M

Market cap

$99.99M

P/E ratio

—

P/S ratio

4,016.22x

EPS (TTM)

$-22.61

Dividend yield

—

52W range

$6 – $40

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$34.63

+210.58%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-9.05M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$8138.00	$0.00	$0.00	$0.00	$7560.00
Net income	$-18.06M	$-17.51M	$2.78M	$-39.72B	$-10.67M
EPS	—	—	—	—	$-22.61
Free cash flow	$-17.04M	$-10.84M	$-27.18M	$-28.12B	$-9.05M
Profit margin	-221,949.66%	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PMN	$99.99M	19	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

ProMIS Neurosciences Inc. trades at $11.15. Our Smart Value Score of 19/100 indicates the stock is weak. TTM revenue stands at $7560.00.

Frequently asked questions

What is ProMIS Neurosciences Inc.'s stock price?

ProMIS Neurosciences Inc. (PMN) trades at $11.15.

Is ProMIS Neurosciences Inc. overvalued?

Smart Value Score 19/100 (Grade F, Strong Sell).

What is the price target of ProMIS Neurosciences Inc. (PMN)?

The analyst target price is $34.63, representing +210.6% upside from the current price of $11.15.

What is ProMIS Neurosciences Inc.'s revenue?

TTM revenue is $7560.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio4,016.22x

ROE-522.00%

Beta-0.16

50D MA$16.02

200D MA$12.78

Shares out0.01B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PMN vs LLY →PMN vs JNJ →PMN vs ABBV →Stock screener →